Board Director Representative Executive Officer, President and CEO of Sosei Group Corporation
- Former Representative Director (CEO) of Genentech Limited (subsidiary in Japan of Genentech Inc.)
- Advised various companies e.g. Genentech, GenPharm, Geron, IDEC, Pharmacyclics, Vernalis and played an important role in completing several significant deals
- Worked for Fujisawa Pharmaceutical Co., Ltd. at various positions in Planning & Development
- Tokyo University graduate with M.S. in Biochemistry and a major in Cultural Anthropology
Takuya FUJII, MBA
External Director
- President and CEO, Promontory Financial Group Global Services Japan LLC
- Former President and CEO, Nippon Credit Bank
- Former Chief Cashier, Bank of Japan
- Former General Secretariat of Policy Board, Bank of Japan
- MBA from the Wharton School of the University of Pennsylvania
- BA in Economics from Tokyo University
Isao MURAMATSU
External Director
- Board Director, Santen Pharmaceutical Co., Ltd.
- Former Board Director and Adviser, GlaxoSmithKline K.K.
- Former Representative Director, SmithKline Beecham Seiyaku K.K.
- Former Representative Director in charge of pharmaceutical business,
Bristol-Myers Squibb K.K.
- Former Board Director and General Manager of Second Sales Division,
Pfizer Japan Inc.
- Graduated from Keio University
Dr. Declan DOOGAN, M.D.
External Director
- Visiting Professor of Drug Development Science, Kitasato University, Tokyo
- Former Senior Vice President, Clinical Research & Development, Pfizer Europe and Japan
- Former Head of Worldwide Development, Pfizer Inc
- Fellow of the Royal College of Physicians of Glasgow and the Faculty of Pharmaceutical Medicine in the UK
- Graduated inmedicine from Glasgow University
